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Berg and colleagues report on the net exchange of amino 
acids and ammonia across the brain in healthy volunteers 
before and 1 hour after a 4-hour endotoxin infusion [1]. 
Amino acids and ammonia were measured in arterial and 
venous plasma, and cerebral blood ﬂ  ow was measured. 
Lipopolysaccharide infusion induced a decrease in the 
ratio between branched chain amino acids (BCAA) and 
aromatic amino acids (AAA). Th  is plasma BCAA/AAA 
ratio (Fischer ratio) was in the past also studied in 
patients with liver failure. In analogy to this situation, the 
decreased BCAA/AAA ratio was mainly the result of a 
decrease in BCAA and to a lesser degree an increase in 
phenylalanine. Th  is led to increased arterial delivery of 
phenylalanine to the brain, altered its unidirectional 
uptake in the brain, and was accompanied by an 
impressive net brain glutamine release. Th  e authors 
speculate that this may be related to increased cerebral 
protein breakdown and that these changes may adversely 
aﬀ   ect brain function (for example, sepsis-associated 
encephalo pathy).
Berg and colleagues’ study is impressive and one that 
may be impossible to perform outside Scandinavia. Th  e 
data are interesting and important, but there are some 
issues that should be highlighted to put the data in 
context. Th  ese issues relate to the analogy with the 
situation in hepatic encephalo  pathy, the accuracy of ﬂ  ux 
measurements, and the potential role of cerebral protein 
breakdown.
During liver failure and associated hyperammonemia, 
ammonia is detoxiﬁ  ed mainly in the brain and muscle by 
the formation of glutamine from ammonia and gluta-
mate. In muscle, BCAA transaminate with α-ketogluta-
rate, yielding glutamate – which may lower plasma 
BCAA. Ammonia may then be coupled to glutamate to 
form glutamine. Th  is glutamine can subsequently be 
exported from the brain (and muscle), which in essence 
means loss of glutamate, an important excitatory 
neurotransmitter. Th   e increased cerebral release of 
glutamine during hyper  ammon  emia could facilitate 
exchange of glutamine for neutral amino acids, notably 
the AAA, by the large neutral amino acid carrier. Th  e 
increased inﬂ  ux of AAA in the brain would raise the 
availability of precursors for neurotransmitters. Phenyl-
alanine and tyrosine may thus disturb brain neurotrans-
mission by promoting synthesis of cerebral catecholamines 
and the false neuro  trans  mitters phenylethanolamine and 
octopamine. Th  e analogy between the situation during 
liver failure and the observations by Berg and colleagues 
during simulated sepsis [1] is striking.
Berg and colleagues did not observe net ammonia 
uptake by the brain, however, and no change in plasma 
ammonia was observed. Equally, no net cerebral phenyl-
alanine uptake was observed, despite increased cerebral 
delivery. Th  e authors calculated unidirectional phenyl-
alanine uptake using a formula derived from the litera-
ture, and found this to be increased. Th   e authors propose 
that the absence of net cerebral phenylalanine uptake 
after lipopolysaccharide infusion does not refute the 
hypothesis that phenylalanine has been taken up by the 
brain. Th   ey speculate this may be due to the 
establishment of a new steady state before the second 
measurement with elevated levels of phenylalanine in the 
cerebrospinal ﬂ  uid. Unidirectional eﬄ   ux of phenylalanine 
was not assessed. It should be realized that if net 
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alanine uptake increases, then unidirectional phenylala-
nine eﬄ   ux must increase to the same extent by deﬁ  nition. 
Th   e question is whether these net ﬂ  ux measure  ments are 
suﬃ   ciently robust to pick up small changes that may play 
a role.
Th  e above certainly holds true for ammonia ﬂ  uxes. 
Lockwood and colleagues (reviewed in [2,3]) have shown 
in situations with relatively low ambient plasma ammonia 
levels that it is impossible to pick up arteriovenous diﬀ  er-
ences across the brain. Th   is may also apply to the present 
study.
Berg and colleagues relate the release of glutamine 
from the brain without concurrent ammonia uptake 
during sepsis to cerebral proteolysis. Cerebral proteolysis 
is important in both health and disease, and may play a 
role in controlling various processes including synaptic 
transmission [4-7]. At the observed magnitude of gluta-
mine eﬄ   ux, however, one wonders why a highly con-
served and protected organ like the brain would exhibit 
such pronounced proteolysis following only a brief 
episode of endotoxemia. What purpose would this serve, 
teleologically? Would the brain not become atrophic 
during prolonged sepsis? Would not a more straight-
forward explanation be that glutamine is transported 
downhill following a concentration gradient resulting 
merely from decreased plasma glutamine during sepsis, 
reﬂ  ecting a change in pool size of cerebral glutamine?
Future research focusing on in-depth analysis of 
ammonia and amino acid exchange across the brain should 
concentrate on three areas. First, because ammonia 
transport across the blood–brain barrier is both carrier 
mediated and pH dependent, data are required on the 
acid–base equilibrium that could be derived from 
(func  tional) proton nuclear magnetic resonance 
measure  ments. Second, a stable isotope methodology 
could be used to measure the unidirectional inﬂ  ux of 
AAA in the brain. Finally, single-photon emission com-
puted tomo  graphy scanning may help unravel important 
details at the tissue level. Th   is approach would also shed 
light on whether protein breakdown does actually play a 
role in brain glutamine release during endotoxemia.
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